Lacriflow CL— 510(k) K170247
Substantially EquivalentKaneka Pharma America, LLC
FDA 510(k) clearance K170247 for Lacriflow CL, Substantially Equivalent on 2017-04-18. Applicant: Kaneka Pharma America, LLC.
Clearance details
- Applicant
- Kaneka Pharma America, LLC
- Product code
- Code OKS
- Advisory panel
- Unknown
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- New York, NY, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.